Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Allergy Clin Immunol. 2019 Sep 4;144(5):1320–1326.e1. doi: 10.1016/j.jaci.2019.07.030

TABLE II.

Peanut SLIT dosing safety and compliance

Peanut SLIT (n = 48)
Total dosing days 78,915
Missed doses 3,549 (4.5%)
Total doses taken 75,366 (95.5%)
Dosing symptoms 3,599 (4.8%)
  Local
    Oropharyngeal pruritus 2699 (3.6%)
    Lip swelling 115 (0.2%)
  Skin 387 (0.5%)
  Upper respiratory tract 75 (0.1%)
  Lower respiratory tract 69 (0.1%)
  Gastrointestinal
    Belly pain 225 (0.3%)
    Vomiting 20 (0.03%)
    Diarrhea 5 (0.01%)
Treatment administered
  Antihistamine 158 (0.2%)
  Epinephrine 0

Upper respiratory tract symptoms included runny nose, sneeze, and nasal congestion. Lower respiratory tract symptoms included cough and wheeze.